Number of subjects | On treatment | Post-treatment | Difference | |
---|---|---|---|---|
Risk class 1B or 1C | 1B: 10; 1C: 25 | -1.02 (-1.77, -0.26) | -5.05 (-6.22, -3.88) | 4.03 (2.70, 5.36), P < 0.001 |
Risk class 1D or 1E | 1D: 31; 1E: 16 | -2.66 (-3.29, -2.04) | -4.84 (-5.63, -4.05) | 2.17 (1.21, 3.13), P < 0.001 |
Female | 42 | -1.59 (-2.32, -0.87) | -5.47 (-6.36, -4.58) | 3.88 (2.80, 4.96), P < 0.001 |
Male | 40 | -2.22 (-2.85, -1.59) | -3.63 (-4.72, -2.53) | 1.41 (0.19, 2.62), P = 0.02 |